rectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Aged 18-80 years regardless of gender; (2)Patients with a confirmed pathological diagnosis of rectal cancer; (3)Patients who have undergone sphincter-preserving surgery for rectal cancer and developed anorectal dysfunction resulting in abnormal defecation with a LARS score = 21; (4)Patients who are at least 6 months post-sphincter-preserving surgery or at least 3 months post-prophylactic ileostomy reversal; (5)Patients with good communication skills capable of completing questionnaires symptom scales and participating in exercises; (6)Patients with good compliance who voluntarily agree to participate and sign an informed consent form prior to enrollment.
Exclusion criteria
Exclusion criteria: (1)Patients with advanced rectal cancer who have tumors or are non-curative post-surgical patients. (2)Patients expected to undergo radiotherapy or chemotherapy during the study period. (3)Patients who have participated in other clinical trials within the past 3 months. (4)Patients with an estimated survival of less than 6 months. (5)Patients with cognitive or psychiatric disorders. (6)Patients with severe cardiovascular pulmonary renal musculoskeletal or balance disorders that prevent them from completing physical exercises.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Memorial Sloan Kettering Cancer Centre (MSKCC) Bowel Function Questionnaire;Low Anterior Resection Syndrome Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Bristol Faecal Shape Scale;TCM spleen deficiency scale;European Organisation for Research and Treatment of Cancer Quality of Survival Core Scale;TCM Kidney deficiency scale;Modified Oxford Scale for Muscle Strength; | — |
Countries
China
Contacts
Xiyuan Hospital of China Academy of Chinese Medical Sciences